Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Abstract Background HCV treatment uptake has drastically increased in HIV-HCV coinfected patients in France since direct-acting antiviral (DAA) treatment approval, resulting in HCV cure in 63% of all HIV-HCV patients by the end of 2015. We investigated the impact of scaling-up DAA on HCV prevalence...
Main Authors: | Victor Virlogeux, Fabien Zoulim, Pascal Pugliese, Isabelle Poizot-Martin, Marc-Antoine Valantin, Lise Cuzin, Jacques Reynes, Eric Billaud, Thomas Huleux, Firouze Bani-Sadr, David Rey, Anne Frésard, Christine Jacomet, Claudine Duvivier, Antoine Cheret, Laurent Hustache-Mathieu, Bruno Hoen, André Cabié, Laurent Cotte, the Dat’AIDS Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12916-017-0979-1 |
Similar Items
-
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection.
by: Pierre Gantner, et al.
Published: (2019-01-01) -
Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.
by: Lise Cuzin, et al.
Published: (2017-01-01) -
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients.
by: Isabelle Poizot-Martin, et al.
Published: (2015-01-01) -
Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.
by: Laurent Cotte, et al.
Published: (2017-01-01) -
Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score.
by: Maxime Hentzien, et al.
Published: (2018-01-01)